Skip to main content
SpringerLink
Log in

Changes in Pulmonary Circulation in Experimental Model of Pulmonary Thromboembolism after Carvedilol Treatment

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

In experiments on isolated perfused rabbit lungs, we studied changes in the pulmonary microcirculation in response to carvedilol injection and after modelling pulmonary thromboembolism under conditions of α1- and β1,2-adrenoceptor blockade with this drug. Carvedilol had mainly vasodilator effects on the pulmonary arterial vessels; the pulmonary venous resistance increased and the capillary filtration coefficient remained unchanged under these conditions. In case of pulmonary thromboembolism against the background of carvedilol treatment, the increase in precapillary resistance and the capillary filtration coefficient was more pronounced that in the control, but the postcapillary resistance increased to a lesser extent. The increase in the capillary filtration coefficient is a result of elevated precapillary resistance and enhanced endothelial permeability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Evlakhov VI, Poyassov IZ, Ovsyannikov VI. Pulmonary Microcirculation in Experimental Model of Pulmonary Thromboembolism under Conditions of α-Adrenoceptor Blockade. Bull. Exp. Biol. Med. 2019;166(3):313-316.

    Article  CAS  Google Scholar 

  2. Minushkina L. Carvedilol in clinical practice. Vrach. 2009;(11):65-69. Russian.

  3. Chazova IЕ, Irodova NL, Krasnikova TL, Arefyeva TI, Lazutkina VK, Orlova YaA, Sokolov SF, Ataullakhanova DM, Masenko VP, Konovatova GG, Lankin VZ. Primary pulmonary hypertension: activation of sympathico-adrenal system and free radical oxidation. Positive effects of carvedilol therapy. Ter. Arkh. 2005;77(4):66-72. Russian.

  4. Bogaard HJ, Natarajan R, Mizuno S, Abbate A, Chang PJ, Chau VQ, Hoke NN, Kraskauskas D, Kasper M, Salloum FN, Voelkel NF. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am. J. Respir. Crit. Care Med. 2010;182(5):652-660.

    Article  CAS  Google Scholar 

  5. Chen Q, Yi B, Ma J, Ning J, Wu L, Ma D, Lu K, Gu J. α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury. Oncotarget. 2016;7(35):55 990-56 001.

    Google Scholar 

  6. Drake JI, Gomez-Arroyo J, Dumur CI, Kraskauskas D, Natarajan R, Bogaard HJ, Fawcett P, Voelkel NF. Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension. Physiol. Genomics. 2013;45(12):449-461.

    Article  CAS  Google Scholar 

  7. Fujio H, Nakamura K, Matsubara H, Kusano KF, Miyaji K, Nagase S, Ikeda T, Ogawa A, Ohta-Ogo K, Miura D, Miura A, Miyazaki M, Date H, Ohe T. Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. J. Cardiovasc. Pharmacol. 2006;47(2):250-255.

    Article  CAS  Google Scholar 

  8. Görnemann T, von Wenckstern H, Kleuser B, Villalón CM, Centurión D, Jähnichen S, Pertz HH. Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins. Br. J. Pharmacol. 2007;151(2):186-194.

    Article  CAS  Google Scholar 

  9. Gomez O, Okumura K, Honjo O, Sun M, Ishii R, Bijnens B, Friedberg MK. Heart rate reduction improves biventricular function and interactions in experimental pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 2018;314(3):H542-H551.

    PubMed  Google Scholar 

  10. Jantschak F, Pertz HH. Alpha2C-adrenoceptors play a prominent role in sympathetic constriction of porcine pulmonary arteries. Naunyn. Schmiedebergs Arch. Pharmacol. 2012;385(6):595-603.

    Article  CAS  Google Scholar 

  11. Okumura K, Kato H, Honjo O, Breitling S, Kuebler WM, Sun M, Friedberg M.K. Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension. J. Mol. Med. (Berl). 2015;93(6):663-674.

    Article  CAS  Google Scholar 

  12. Yang J, Sun H, Zhang J, Hu M, Wang J, Wu G, Wang G. Regulation of β-adrenergic receptor trafficking and lung microvascular endothelial cell permeability by Rab5 GTPase. Int. J. Biol. Sci. 2015;11(8):868-878.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Physiology of Visceral System, Institute of Experimental Medicine, St. Petersburg, Russia

    I. Evlakhov, I. Z. Poyassov & V. I. Ovsyannikov

Authors
  1. I. Evlakhov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Z. Poyassov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. I. Ovsyannikov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Evlakhov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 167, No. 4, pp. 413-416, April, 2019

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Evlakhov, I., Poyassov, I.Z. & Ovsyannikov, V.I. Changes in Pulmonary Circulation in Experimental Model of Pulmonary Thromboembolism after Carvedilol Treatment. Bull Exp Biol Med 167, 432–435 (2019). https://doi.org/10.1007/s10517-019-04543-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-019-04543-8

Key Words

Search

Navigation